{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:56:49Z","timestamp":1793332609397,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,2,10]],"date-time":"2018-02-10T00:00:00Z","timestamp":1518220800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the National Key Research and Development Programme of China","award":["2016YFA0201400"],"award-info":[{"award-number":["2016YFA0201400"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s00404-018-4699-3","type":"journal-article","created":{"date-parts":[[2018,2,10]],"date-time":"2018-02-10T00:15:02Z","timestamp":1518221702000},"page":"1235-1244","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Overexpression of GPNMB predicts an unfavorable outcome of epithelial ovarian cancer"],"prefix":"10.1007","volume":"297","author":[{"given":"Rui-qiong","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-jian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-yan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-kun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-hong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1526-8408","authenticated-orcid":false,"given":"Heng","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,10]]},"reference":[{"key":"4699_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63:11\u201330. \n                    https:\/\/doi.org\/10.3322\/caac.21166","journal-title":"CA Cancer J Clin"},{"key":"4699_CR2","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3322\/caac.20121","volume":"61","author":"R Siegel","year":"2011","unstructured":"Siegel R, Ward E, Brawley O, Jemal A (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61:212\u2013236. \n                    https:\/\/doi.org\/10.3322\/caac.20121","journal-title":"CA Cancer J Clin"},{"key":"4699_CR3","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1097\/IGC.0000000000000007","volume":"23","author":"P Amate","year":"2013","unstructured":"Amate P, Huchon C, Dessapt AL et al (2013) Ovarian cancer: sites of recurrence. Int J Gynecol Cancer 23:1590\u20131596. \n                    https:\/\/doi.org\/10.1097\/IGC.0000000000000007","journal-title":"Int J Gynecol Cancer"},{"key":"4699_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1615\/CritRevEukaryotGeneExpr.v13.i24.130","volume":"13","author":"TA Owen","year":"2003","unstructured":"Owen TA, Smock SL, Prakash S et al (2003) Identification and characterization of the genes encoding human and mouse osteoactivin. Crit Rev Eukaryot Gene Expr 13:205\u2013220. \n                    https:\/\/doi.org\/10.1615\/CritRevEukaryotGeneExpr.v13.i24.130","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"4699_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/ijc.2910600111","volume":"60","author":"MA Weterman","year":"1995","unstructured":"Weterman MA, Ajubi N, van Dinter IM et al (1995) nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts. Int J Cancer 60:73\u201381. \n                    https:\/\/doi.org\/10.1002\/ijc.2910600111","journal-title":"Int J Cancer"},{"key":"4699_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/ng794","volume":"30","author":"MG Anderson","year":"2002","unstructured":"Anderson MG, Smith RS, Hawes NL et al (2002) Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA\/2J mice. Nat Genet 30:81\u201385. \n                    https:\/\/doi.org\/10.1038\/ng794","journal-title":"Nat Genet"},{"key":"4699_CR7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.gene.2008.01.014","volume":"413","author":"VM Ripoll","year":"2008","unstructured":"Ripoll VM, Meadows NA, Raggatt LJ et al (2008) Microphthalmia transcription factor regulates the expression of the novel osteoclast factor GPNMB. Gene 413:32\u201341. \n                    https:\/\/doi.org\/10.1016\/j.gene.2008.01.014","journal-title":"Gene"},{"key":"4699_CR8","doi-asserted-by":"publisher","first-page":"e35280","DOI":"10.1371\/journal.pone.0035280","volume":"7","author":"MH Sheng","year":"2012","unstructured":"Sheng MH, Wergedal JE, Mohan S et al (2012) Targeted overexpression of osteoactivin in cells of osteoclastic lineage promotes osteoclastic resorption and bone loss in mice. PLoS One 7:e35280. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0035280","journal-title":"PLoS One"},{"key":"4699_CR9","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/eji.200838990","volume":"39","author":"JS Chung","year":"2009","unstructured":"Chung JS, Bonkobara M, Tomihari M et al (2009) The DC-HIL\/syndecan-4 pathway inhibits human allogeneic T-cell responses. Eur J Immunol 39:965\u2013974. \n                    https:\/\/doi.org\/10.1002\/eji.200838990","journal-title":"Eur J Immunol"},{"key":"4699_CR10","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1096\/fj.09-151019","volume":"24","author":"T Hoashi","year":"2010","unstructured":"Hoashi T, Sato S, Yamaguchi Y et al (2010) Glycoprotein nonmetastatic melanoma protein b, a melanocytic cell marker, is a melanosome-specific and proteolytically released protein. FASEB J 24:1616\u20131629. \n                    https:\/\/doi.org\/10.1096\/fj.09-151019","journal-title":"FASEB J"},{"key":"4699_CR11","doi-asserted-by":"publisher","first-page":"4767","DOI":"10.1096\/fj.10-154757","volume":"24","author":"B Li","year":"2010","unstructured":"Li B, Castano AP, Hudson TE et al (2010) The melanoma-associated transmembrane glycoprotein Gpnmb controls trafficking of cellular debris for degradation and is essential for tissue repair. FASEB J 24:4767\u20134781. \n                    https:\/\/doi.org\/10.1096\/fj.10-154757","journal-title":"FASEB J"},{"key":"4699_CR12","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/CMR.0b013e3283364a08","volume":"20","author":"MD Williams","year":"2010","unstructured":"Williams MD, Esmaeli B, Soheili A et al (2010) GPNMB expression in uveal melanoma: a potential for targeted therapy. Melanoma Res 20:184\u2013190. \n                    https:\/\/doi.org\/10.1097\/CMR.0b013e3283364a08","journal-title":"Melanoma Res"},{"key":"4699_CR13","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.3760\/cma.j.issn.0366-6999.2012.18.015","volume":"125","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Qiao ZG, Shan SJ et al (2012) Expression of glycoprotein non-metastatic melanoma protein B in cutaneous malignant and benign lesions: a tissue microarray study. Chin Med J (Engl) 125:1382\u20133279. \n                    https:\/\/doi.org\/10.3760\/cma.j.issn.0366-6999.2012.18.015","journal-title":"Chin Med J (Engl)"},{"key":"4699_CR14","doi-asserted-by":"publisher","first-page":"15951","DOI":"10.1074\/jbc.M211498200","volume":"278","author":"JN Rich","year":"2003","unstructured":"Rich JN, Shi Q, Hjelmeland M et al (2003) Bone-related genes expressed in advanced malignancies induce invasion and metastasis in a genetically defined human cancer model. J Biol Chem 278:15951\u201315957. \n                    https:\/\/doi.org\/10.1074\/jbc.M211498200","journal-title":"J Biol Chem"},{"key":"4699_CR15","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3727\/096504013X13657689382851","volume":"20","author":"F Tian","year":"2013","unstructured":"Tian F, Liu C, Wu Q et al (2013) Upregulation of glycoprotein nonmetastatic B by colony-stimulating factor-1 and epithelial cell adhesion molecule in hepatocellular carcinoma cells. Oncol Res 20:341\u2013350. \n                    https:\/\/doi.org\/10.3727\/096504013X13657689382851","journal-title":"Oncol Res"},{"key":"4699_CR16","doi-asserted-by":"publisher","first-page":"e76251","DOI":"10.1371\/journal.pone.0076251","volume":"8","author":"H Eldai","year":"2013","unstructured":"Eldai H, Periyasamy S, Al Qarni S et al (2013) Novel genes associated with colorectal cancer are revealed by high resolution cytogenetic analysis in a patient specific manner. PLoS One 8:e76251. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0076251","journal-title":"PLoS One"},{"key":"4699_CR17","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1002\/cam4.480","volume":"4","author":"M Kanematsu","year":"2015","unstructured":"Kanematsu M, Futamura M, Takata M et al (2015) Clinical significance of glycoprotein nonmetastatic B and its association with HER2 in breast cancer. Cancer Med 4:1344\u20131355. \n                    https:\/\/doi.org\/10.1002\/cam4.480","journal-title":"Cancer Med"},{"key":"4699_CR18","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1158\/1078-0432.CCR-09-1611","volume":"16","author":"AA Rose","year":"2010","unstructured":"Rose AA, Grosset AA, Dong Z et al (2010) Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer. Clin Cancer Res 16:2147\u20132156. \n                    https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-1611","journal-title":"Clin Cancer Res"},{"key":"4699_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1471-2407-9-11","volume":"9","author":"CL Estilo","year":"2009","unstructured":"Estilo CL, O-charoenrat P, Talbot S et al (2009) Oral tongue cancer gene expression profiling: identification of novel potential prognosticators by oligonucleotide microarray analysis. BMC Cancer 9:11. \n                    https:\/\/doi.org\/10.1186\/1471-2407-9-11","journal-title":"BMC Cancer"},{"key":"4699_CR20","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.2353\/ajpath.2010.090950","volume":"176","author":"ME Tyburczy","year":"2010","unstructured":"Tyburczy ME, Kotulska K, Pokarowski P et al (2010) Novel proteins regulated by mTOR in subependymal giant cell astrocytomas of patients with tuberous sclerosis complex and new therapeutic implications. Am J Pathol 176:1878\u20131890. \n                    https:\/\/doi.org\/10.2353\/ajpath.2010.090950","journal-title":"Am J Pathol"},{"key":"4699_CR21","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S0168-8278(03)00361-1","volume":"39","author":"M Onaga","year":"2003","unstructured":"Onaga M, Ido A, Hasuike S et al (2003) Osteoactivin expressed during cirrhosis development in rats fed a choline-deficient, l-amino acid-defined diet, accelerates motility of hepatoma cells. J Hepatol 39:779\u2013785. \n                    https:\/\/doi.org\/10.1016\/S0168-8278(03)00361-1","journal-title":"J Hepatol"},{"key":"4699_CR22","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.humpath.2011.05.002","volume":"43","author":"MG Prisco","year":"2012","unstructured":"Prisco MG, Zannoni GF, De Stefano I et al (2012) Prognostic role of metastasis tumor antigen 1 in patients with ovarian cancer: a clinical study. Hum Pathol 43:282\u2013288. \n                    https:\/\/doi.org\/10.1016\/j.humpath.2011.05.002","journal-title":"Hum Pathol"},{"key":"4699_CR23","doi-asserted-by":"publisher","first-page":"839","DOI":"10.2147\/OTT.S44906","volume":"6","author":"G Maric","year":"2013","unstructured":"Maric G, Rose AA, Annis MG et al (2013) Glycoprotein non-metastatic b (GPNMB): a metastatic mediator and emerging therapeutic target in cancer. Onco Targets Ther 6:839\u2013852. \n                    https:\/\/doi.org\/10.2147\/OTT.S44906","journal-title":"Onco Targets Ther"},{"key":"4699_CR24","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1158\/1541-7786.MCR-07-0119","volume":"5","author":"AA Rose","year":"2007","unstructured":"Rose AA, Pepin F, Russo C et al (2007) Osteoactivin promotes breast cancer metastasis to bone. Mol Cancer Res 5:1001\u20131014. \n                    https:\/\/doi.org\/10.1158\/1541-7786.MCR-07-0119","journal-title":"Mol Cancer Res"},{"key":"4699_CR25","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3892\/mmr.2014.1896","volume":"9","author":"C Qin","year":"2014","unstructured":"Qin C, Liu Z, Yuan Y et al (2014) Glycoprotein non-metastatic melanoma protein B as a predictive prognostic factor in clear-cell renal cell carcinoma following radical nephrectomy. Mol Med Rep 9:851\u2013856. \n                    https:\/\/doi.org\/10.3892\/mmr.2014.1896","journal-title":"Mol Med Rep"},{"key":"4699_CR26","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1158\/1078-0432.CCR-05-2797","volume":"12","author":"CT Kuan","year":"2006","unstructured":"Kuan CT, Wakiya K, Dowell JM et al (2006) Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme. Clin Cancer Res 12:1970\u20131982. \n                    https:\/\/doi.org\/10.1158\/1078-0432.CCR-05-2797","journal-title":"Clin Cancer Res"},{"key":"4699_CR27","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/apm.12107","volume":"122","author":"YN Li","year":"2014","unstructured":"Li YN, Zhang L, Li XL et al (2014) Glycoprotein nonmetastatic B as a prognostic indicator in small cell lung cancer. APMIS 122:140\u2013146. \n                    https:\/\/doi.org\/10.1111\/apm.12107","journal-title":"APMIS"},{"key":"4699_CR28","doi-asserted-by":"publisher","first-page":"e7012","DOI":"10.1371\/journal.pone.0007012","volume":"4","author":"P Mokarram","year":"2009","unstructured":"Mokarram P, Kumar K, Brim H et al (2009) Distinct high-profile methylated genes in colorectal cancer. PLoS One 4:e7012. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0007012","journal-title":"PLoS One"},{"key":"4699_CR29","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.yexcr.2014.02.025","volume":"323","author":"C Fiorentini","year":"2014","unstructured":"Fiorentini C, Bodei S, Bedussi F et al (2014) GPNMB\/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity. Exp Cell Res 323:100\u2013111. \n                    https:\/\/doi.org\/10.1016\/j.yexcr.2014.02.025","journal-title":"Exp Cell Res"},{"key":"4699_CR30","doi-asserted-by":"publisher","first-page":"5778","DOI":"10.1158\/0008-5472.CAN-09-2538","volume":"70","author":"M Tomihari","year":"2010","unstructured":"Tomihari M, Chung JS, Akiyoshi H et al (2010) DC-HIL\/glycoprotein Nmb promotes growth of melanoma in mice by inhibiting the activation of tumor-reactive T cells. Cancer Res 70:5778\u20135787. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-2538","journal-title":"Cancer Res"},{"key":"4699_CR31","doi-asserted-by":"publisher","first-page":"e12093","DOI":"10.1371\/journal.pone.0012093","volume":"5","author":"AA Rose","year":"2010","unstructured":"Rose AA, Annis MG, Dong Z et al (2010) ADAM10 releases a soluble form of the GPNMB\/Osteoactivin extracellular domain with angiogenic properties. PLoS One 5:e12093. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0012093","journal-title":"PLoS One"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-018-4699-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-018-4699-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-018-4699-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T20:23:14Z","timestamp":1549743794000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-018-4699-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,10]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["4699"],"URL":"https:\/\/doi.org\/10.1007\/s00404-018-4699-3","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,10]]},"assertion":[{"value":"31 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Tissues from human participants are adopted in the current study. All procedures performed in studies involving human participants should be in strict accordance with the ethical standards of the Institute Research Ethics Committee of Peking University People\u2019s Hospital as well as the Helsinki declaration (1964) and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study involving human participants"}},{"value":"Informed consent is obtained from all participants enrolled in the current study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}